Carmignac Gestion’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Carmignac Gestion's TEVA Position: Q1 2015 in Review
Carmignac Gestion sold out of Teva Pharmaceutical Industries (TEVA) in Q1 2015, closing a stake of 6,116,302 shares — an estimated $352M sold.
Carmignac Gestion first reported a position in TEVA in Q4 2014 and held it in 1 quarter. The position peaked at $352M in Q4 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.
- Carmignac Gestion reported no remaining Teva Pharmaceutical Industries position as of Q1 2015 after selling out during the quarter.
- Carmignac Gestion sold 6,116,302 Teva Pharmaceutical Industries shares in Q1 2015, an estimated $352M.
- Carmignac Gestion first reported a position in Teva Pharmaceutical Industries in Q4 2014 and held it in 1 quarter.
- Carmignac Gestion's Teva Pharmaceutical Industries position peaked at $352M in Q4 2014.
- 822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q1 2015.
Based on Carmignac Gestion's 13F filing for Q1 2015, filed 11 May 2015.